Cian Healthcare P/B Ratio
CHCL • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
0.39
Low Valuation
Very Low - Significant discount to book value, potential distress or value opportunity
Current Valuation Metrics
P/B Ratio
0.39
Current Price
₹
Book Value/Share
₹12.80
Exchange
None
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹32 Cr
Share Capital
₹25 Cr
Reserves & Surplus
₹7 Cr
Outstanding Shares
25,000,000
Book Value per Share
₹12.80
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
-0.14
Sector Median
0.69
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Cian Healthcare
- Stock appears undervalued with PB of 0.39, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Trading at premium to sector average PB of -0.14
View the current stock price of Cian Healthcare for more insights.
Related Pages for Cian Healthcare
Additional stock information and data for CHCL
Sector P/B Ratio Comparison
Comparing Cian Healthcare with other companies in Healthcare sector
Sector Average
-0.14
Sector Median
0.69
Lowest P/B
-12.06
Highest P/B
1.13
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.06 | ₹4,124 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.67 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |